MedPath

DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant Hypertension

Phase 3
Terminated
Conditions
Hypertension
Interventions
Registration Number
NCT00353574
Lead Sponsor
Gilead Sciences
Brief Summary

This is a research study of a new experimental drug called darusentan. Darusentan is not currently approved by the United States (U.S.) Food and Drug Administration (FDA) for use in the U.S., which means that a doctor cannot prescribe this drug. The purpose of this study is to evaluate the long-term safety of darusentan in subjects with resistant systolic hypertension despite treatment with full doses of three or more antihypertensive medications, including a diuretic.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
282
Inclusion Criteria
  • Subjects who have completed the Treatment Period of clinical trial DAR-311
  • Receiving and adhering to full doses of appropriate guideline-recommended antihypertensive drugs from three different classes of antihypertensive agents, including a diuretic
Exclusion Criteria
  • Subjects who discontinued treatment with study drug prior to the end of the Treatment Period of DAR-311 due to a study drug-related adverse event (AE)
  • Treatment with another endothelin receptor antagonist within 6 months of study entry

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Darusentan 50 mgDarusentanDarusentan 50 mg administered orally once daily
Darusentan 100 mgDarusentanDarusentan 100 mg administered orally once daily
Darusentan 300 mgDarusentanDarusentan 300 mg administered orally once daily
Primary Outcome Measures
NameTimeMethod
Change in trough sitting systolic and diastolic blood pressureBaseline to Week 14
Secondary Outcome Measures
NameTimeMethod
Change in mean 24-hour systolic and diastolic ambulatory blood pressures.Baseline to Week 14
Percentage of subjects who reach systolic blood pressure goalWeek 14
Change in estimated glomerular filtration rate (eGFR)Baseline to Week 14

Trial Locations

Locations (74)

Apex Research Institute

🇺🇸

Santa Ana, California, United States

Cardiovascular Center of Sarasota

🇺🇸

Sarasota, Florida, United States

Castlerock Clinical Research Consultants

🇺🇸

Tulsa, Oklahoma, United States

Temple University Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

International Research Association

🇺🇸

Miami, Florida, United States

The Lindner Clinical Trial Center

🇺🇸

Cincinnati, Ohio, United States

Hvidovre Hospital

🇩🇰

Hvidovre, Denmark

Bispebjerg Hospital

🇩🇰

København, Denmark

Complete Renal Care

🇺🇸

Denver, Colorado, United States

Townhead Surgery

🇬🇧

Scotland, United Kingdom

Avenue Surgery

🇬🇧

Wiltshire, United Kingdom

Heritage Cardiology Associates

🇺🇸

Camp Hill, Pennsylvania, United States

CIC Hopital Jeanne D'Arc

🇫🇷

Dommartin les Toul, France

COR Clinical Research

🇺🇸

Oklahoma City, Oklahoma, United States

Burke Internal Medicine, Inc.

🇺🇸

Burke, Virginia, United States

Hospital Jose Maria Ramos Meijia

🇦🇷

Buenos Aires, Argentina

Connecticut Clinical Research, LLC

🇺🇸

Bridgeport, Connecticut, United States

Chicago Heart & Vein Clinic

🇺🇸

Elk Grove Village, Illinois, United States

Internal Medicine & Industrial Medicine

🇺🇸

Desoto, Texas, United States

CIMEL

🇦🇷

Buenos Aires, Argentina

Fundapres

🇦🇷

Buenos Aires, Argentina

Hathaway Medical Centre

🇬🇧

Wiltshire, United Kingdom

Androscoggin Cardiology Associates

🇺🇸

Auburn, Maine, United States

Clinical Associates

🇺🇸

Reisterstown, Maryland, United States

Hillsboro Cardiology, PC

🇺🇸

Hillsboro, Oregon, United States

Cardiovascular Research, Karolinska Institue

🇸🇪

Stockholm, Sweden

Evanston Northwestern Healthcare

🇺🇸

Evanston, Illinois, United States

Centro Integrado Hospital do Rim e Hipertensao

🇧🇷

Sao Paulo, Brazil

RI Hospital

🇺🇸

Providence, Rhode Island, United States

Liberty Research Center

🇺🇸

Tacoma, Washington, United States

White-Wilson Medical Center

🇺🇸

Fort Walton Beach, Florida, United States

Cambridge Cardiac Care Center

🇨🇦

Cambridge, Ontario, Canada

Brandywine Clinical Research

🇺🇸

Downingtown, Pennsylvania, United States

University Hospital Umea

🇸🇪

Umea, Sweden

Cardiovascular Consultants of Maine

🇺🇸

Scarborough, Maine, United States

VA Medical Center - WLA

🇺🇸

Los Angeles, California, United States

Medical Research Institute

🇺🇸

Slidell, Louisiana, United States

Specialty Medical Center

🇺🇸

Pahrump, Nevada, United States

Chrishard Medical Group

🇺🇸

Inglewood, California, United States

Clinical Investigation Specialists, Inc.

🇺🇸

Gurnee, Illinois, United States

Comprehensive Heart Failure Center

🇺🇸

Mobile, Alabama, United States

Canyon Clinical Research

🇺🇸

Tucson, Arizona, United States

Global Research Partners

🇺🇸

Calhoun, Georgia, United States

Rockville Internal Medicine Group

🇺🇸

Rockville, Maryland, United States

T&R Clinical, P.A.

🇺🇸

Ft Worth, Texas, United States

Midwest Heart Foundation

🇺🇸

Lombard, Illinois, United States

Hospital Britanico de Buenos Aires

🇦🇷

Buenos Aires, Argentina

Manassas Clinical Research Center

🇺🇸

Manassas, Virginia, United States

CHU de Grenoble

🇫🇷

Grenoble Cedex, France

Professional Clinical Research

🇺🇸

Interlochen, Michigan, United States

Sanatorio Municipal

🇦🇷

Buenos Aires, Argentina

Tampa Bay Nephrology Associates, PL

🇺🇸

Tampa, Florida, United States

Metabolic Research Institute, Inc.

🇺🇸

West Palm Beach, Florida, United States

Innovative Clinical Trials

🇺🇸

San Antonio, Texas, United States

Green and Seidner Family Practice Associates

🇺🇸

Lansdale, Pennsylvania, United States

MedStar Diabetes Institute at Washington Hospital Center

🇺🇸

Washington, District of Columbia, United States

Jacksonville Center for Clinical

🇺🇸

Jacksonville, Florida, United States

A.G.A. Clinical Trials

🇺🇸

Hialeah, Florida, United States

Ricardo A. Bedoya, Cardiology

🇺🇸

Jupiter, Florida, United States

Hurley Medical Center

🇺🇸

Flint, Michigan, United States

Southwest Cardiology Associates

🇺🇸

Oklahoma City, Oklahoma, United States

Northeast Clinical Research Centers, Inc.

🇺🇸

Allentown, Pennsylvania, United States

Neem Research Group, Inc.

🇺🇸

Columbia, South Carolina, United States

DIM (Clinica Privada)

🇦🇷

Buenos Aires, Argentina

Hospital Municipal Bernardo Houssay

🇦🇷

Buenos Aires, Argentina

Medeos

🇦🇷

Buenos Aires, Argentina

Centro Integrado Hospital

🇧🇷

Sao Paulo, Brazil

Hôpital Civil, Service HTA maladies vasculaires

🇫🇷

Strasbourg Cedex, France

Clinical Research Solutions

🇨🇦

Kitchener, Ontario, Canada

Kula Research

🇺🇸

Honolulu, Hawaii, United States

Maine Research Associate

🇺🇸

Auburn, Maine, United States

Physicians East, PA

🇺🇸

Greenville, North Carolina, United States

Pri-Med Care

🇺🇸

Lewisville, Texas, United States

Sacramento Heart and Vascular

🇺🇸

Sacramento, California, United States

© Copyright 2025. All Rights Reserved by MedPath